Generate a tailored SOP for Dr. Timothy Illidge. Improve your application with a focused, well-structured draft.
Professor Timothy Illidge is a prominent figure at the University of Manchester specializing in Targeted Therapy and Oncology. He also serves as an Honorary Consultant in Clinical Oncology at Christie Hospital NHS Foundation Trust. His research primarily focuses on radiotherapy, exploring its immunomodulatory properties and potential to significantly increase anti-cancer effects when combined with immune checkpoint inhibitors. With a well-established background in tumor immunology and radiobiology, Professor Illidge has contributed to the development of new class therapeutics in the field of immuno-oncology. His research aims to translate radiotherapy and immunotherapy combinations to enhance cancer treatment outcomes. He is actively involved in various research projects and collaborations within the cancer research community, aiming to improve treatment strategies for patients with various types of malignancies.
University of Manchester • Manchester, England
Leading research in targeted therapy and oncology, with a focus on immunomodulatory effects of radiotherapy.
Includes MSc in Advanced Electrical Power Systems and MSc in Communications and Signal Processing.